Summit Securities Group’s SpringWorks Therapeutics SWTX Stock Holding History

Summit Securities Group’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,000	Closed	-$235K	–	1345
2025 Q2	$235K	Buy	5,000 +340	+7%	+$15.1K	0.05%	241
2025 Q1	$206K	Buy	+4,660	New	+$215K	0.03%	172

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Summit Securities Group's SWTX Position: Q3 2025 in Review

Summit Securities Group sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 5,000 shares — an estimated $235K sold.

Summit Securities Group first reported a position in SWTX in Q1 2025 and held it in 2 quarters. The position peaked at $235K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Summit Securities Group reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Summit Securities Group sold 5,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $235K.
Summit Securities Group first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 2 quarters.
Summit Securities Group's SpringWorks Therapeutics position peaked at $235K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Summit Securities Group's 13F filing for Q3 2025, filed 13 Nov 2025.